hotspot -WSS

hotspot

author：comprehensive 2025-10-01 23:38:34 - browse：4

Liver illustration — Hyacinth Empinado/STAT

SAN DIEGO — The American Diabetes Association said Sunday that all adults with type 2 diabetes or prediabetes should be screened for nonalcoholic fatty liver disease, an increasingly prevalent condition that can lead to serious liver damage.

There are no approved medications for the disease, but among available diabetes drugs, the ADA singled out GLP-1 treatments as an option doctors could consider, according to recommendations published during the annual ADA conference.

GLP-1 treatments, such as Ozempic and Mounjaro, are a class of drugs that have grown widely popular for their efficacy not only in lowering blood sugar, but also cutting weight. Drugmakers have started to study them in liver disease, and while some trials have shown they may offer some benefits, they haven’t yet been shown to improve harmful liver scarring.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Even great ERs can’t make up for American health disparities

entertainment

WSS

SAMSHA loosens regulations on methadone treatment centers

Even great ERs can’t make up for American health disparities

Time to name cancers by genetics, not organ of origin, expert says

A $475,000 price tag for a new cancer drug: crazy or meh?

Do digital therapeutics have a future in medicine?

Woodcock on FDA’s accelerated approval and her next chapter

focus

hotspot

explore

Malaria cases in Florida and Texas: Here’s what you need to know

Juul spent big to court Black leaders to promote its e

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Do digital therapeutics have a future in medicine?

Supreme Court strikes down use of affirmative action

Even great ERs can’t make up for American health disparities

Anesthesiologist group: stop taking Ozempic before surgery

Biden administration opens offers in Medicare drug price negotiations

Alkermes shareholders re

Woodcock on FDA’s accelerated approval and her next chapter

hotspot

Covid misinformation case heads to Supreme Court

ARCH Venture Partners is raising $3 billion for a life sciences fund

Novo Nordisk to expand supply of Wegovy for U.S. patients

Medicare drug price negotiation’s day in court

Do digital therapeutics have a future in medicine?

The lessons of Aduhelm, an Alzheimer's drug that was not to be

entertainment

leisure time

explore

Wikipedia